Cite

HARVARD Citation

    Fehmi, J. et al. (2021). IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality. Journal of neurology, neurosurgery and psychiatry. 92 (10), pp. 1089-1095. [Online]. 
  
Back to record